NEW YORK (GenomeWeb) – The National Institutes of Health this month earmarked more than $1.4 million in funding to support five research projects investigating microRNAs in cancer progression and treatment response.

The first grant was awarded to Scripps Research Institute scientist Peiqing Sun to build off work previously conducted in his lab showing that one cancer-associated miRNA — miR-30 — disrupts a key tumor-suppressing mechanism, known as Ras-induced senescence, by targeting the transcriptional co-activator CHD7 and an RNA-binding protein called TNRC6A.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.